Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • U vs MRNA✓SelectedUSD · MRNAU vs MRNA performance historyLatest closeAs of-4.62%11/19
Stock and ETF performance explorer

U vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.7%
MRNA return
+191.9%
Excess return
-223.6%
Maximum drawdown
-93.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.6%+1.3%-5.9%-4.8%
7D-6.9%-13.8%+6.9%-5.1%
30D+16.3%-17.7%+33.9%+18.7%
3M-0.9%+14.3%-15.2%-4.6%
6M+78.2%+336.0%-257.7%+15.5%
YTD+5.7%+575.9%-570.2%-41.9%
1Y+19.1%+724.4%-705.3%-38.9%
3Y+59.9%+160.8%-100.8%+5.3%
5Y-75.4%-24.4%-51.0%-77.9%
All-31.7%+191.9%-223.6%-62.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling